The Prognostic Value of the Proliferation Marker Phosphohistone H3 (PPH3) in Luminal, Basal-Like and Triple Negative Phenotype Invasive Lymph Node-Negative Breast Cancer

The Prognostic Value of the Proliferation Marker Phosphohistone H3 (PPH3) in Luminal, Basal-Like and Triple Negative Phenotype Invasive Lymph Node-Negative Breast Cancer

Purpose: Prognostic comparison of phosphohistone-H3 (PPH3) with Cytokeratin 5/6 and/or 14 positive (= basal-CK), triple (ER, PR, HER2)-negative (= TNP) and basal-like (= TNP and basal-CK positive) phenotype in invasive breast cancers.

Saved in:

Bibliographic Details
Main Authors:	Ivar Skaland, Emiel A. M. Janssen, Einar Gudlaugsson, Lydia Hui Ru Guo, Jan P. A. Baak
Format:	Article
Language:	English
Published:	Wiley 2009-01-01
Series:	Cellular Oncology
Online Access:	http://dx.doi.org/10.3233/CLO-2009-0464
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prognostic value of gene signatures and proliferation in lymph-node-negative breast cancer.
by: Kristin Jonsdottir, et al.
Published: (2014-01-01)

LOH at 1p31 (ARHI) and Proliferation in Lymph Node-Negative Breast Cancer
by: Emiel A. M. Janssen, et al.
Published: (2009-01-01)

Cell-cycle and Apoptosis Regulators (p16INK4A, p21CIP1, α-Catenin, Survivin, and hTERT) and Morphometry-Defined MPECs Predict Metachronous Cancer Development in Colorectal Adenoma Patients
by: Kjetil Soreide, et al.
Published: (2007-01-01)

PREDICTIVE VALUE OF MOLECULAR PARAMETERS IN PATIENTS WITH BASAL-LIKE TRIPL-NEGATIVE BREAST CANCER
by: О. D. Bragina, et al.
Published: (2016-02-01)

Phosphohistone H3 as the standard of immunohistochemical study in the assessment of differentiation level of oropharyngeal zone squamous cell carcinomas
by: А. V. Lysak, et al.
Published: (2016-08-01)

Caveolin-1 in Tumour Cells is Predominately Expressed in the Basal Subtype of Triple-Negative Breast Carcinoma
by: Savelina Popovska, et al.
Published: (2014-11-01)

Anti-phosphohistone H3 (PHH3) as a proliferation marker to assess mitotic activity and to grade neuroendocrine neoplasms of hepatopancreaticobiliary (HPB) system
by: A Prisca Santhanam, et al.
Published: (2025-01-01)

Success Predictors of Adjuvant Chemotherapy in Node-Negative Breast Cancer Patients Under 55 years1
by: Emiel A. M. Janssen, et al.
Published: (2006-01-01)

Quantitative and Qualitative Variations in TILs in Risk Stratification and Patient Selection for Neoadjuvant Chemotherapy of the Luminal B and Triple-Negative Breast Cancer Immunophenotype
by: Ana Car Peterko, et al.
Published: (2025-05-01)

Selisistat, a SIRT1 inhibitor, enhances paclitaxel activity in luminal and triple-negative breast cancer: in silico, in vitro, and in vivo studies
by: Anna Wawruszak, et al.
Published: (2025-12-01)

Author Correction: Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification
by: Miseon Lee, et al.
Published: (2025-03-01)

Treatment of luminal HER2-negative breast cancer: opinion of experts
by: E. V. Artemeva, et al.
Published: (2024-06-01)

The differences in ultrasound and clinicopathological features between basal-like and normal-like subtypes of triple negative breast cancer.
by: Ziyao Li, et al.
Published: (2015-01-01)

Metals in Organic Syntheses. II. The Effect of Molecular Hydrogen on the Highly Regioselective Hydrocarboxylation of Propene Promoted by a [PdCl2(PPh3)2]-PPh3 Catalyst Precursor
by: G. Cavinato, et al.
Published: (1979-08-01)

Elevated preoperative serum levels of collagen I carboxyterminal telopeptide predict better outcome in early-stage luminal-B-like (HER2-negative) and triple-negative subtypes of breast cancer
by: Anniina Jääskeläinen, et al.
Published: (2019-05-01)

Triple-Negative Breast Cancer
by: Quyen D. Chu, et al.
Published: (2012-01-01)

Log odds of positive lymph nodes as a prognostic marker in resectable triple negative breast cancer
by: Chenchen Zheng, et al.
Published: (2025-08-01)

Preliminary characterisation of the spatial immune and vascular environment in triple negative basal breast carcinomas using multiplex fluorescent immunohistochemistry.
by: Elena A Takano, et al.
Published: (2025-01-01)

Delineation of the Germline and Somatic Mutation Interaction Landscape in Triple-Negative and Non-Triple-Negative Breast Cancer
by: Jiande Wu, et al.
Published: (2020-01-01)

High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis
by: Andreas Hagen Røssevold, et al.
Published: (2025-06-01)

Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function
by: Annat Raiter, et al.
Published: (2025-02-01)

Prediction of axillary lymph node metastasis in triple negative breast cancer using MRI radiomics and clinical features
by: Yunyun Shen, et al.
Published: (2025-07-01)

TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017-06-01)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020-09-01)

Molecular profiling of breast cancer methylation pattern in triple negative versus non- triple negative breast cancer
by: Marwa Mohanad, et al.
Published: (2025-02-01)

Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer
by: Elie Dagher, et al.
Published: (2020-01-01)

AFF3 is a Prognostic Biomarker Correlated with Immune Infiltrates in Triple-Negative Breast Cancer
by: Jing Chen, et al.
Published: (2023-08-01)

Co-Inhibition of PARP and STAT3 as a Promising Approach for Triple-Negative Breast Cancer
by: Changyou Shi, et al.
Published: (2025-07-01)

Clinical Association of Negative Lymph Nodes With Adjuvant Chemotherapy in Patients With T3N0 Rectal Cancer
by: Dongxu Lei, et al.
Published: (2025-01-01)

Predictive and prognostic features of early and locally advanced <i>PIK3CA</i>-mutated luminal HER2-negative breast cancer
by: A. I. Stukan, et al.
Published: (2024-01-01)

Reporters to mark and eliminate basal or luminal epithelial cells in culture and in vivo.
by: Olmo Sonzogni, et al.
Published: (2018-06-01)

Brain Metastasis in Triple-Negative Breast Cancer
by: Eduarda Bustamante, et al.
Published: (2024-01-01)

Collagen architecture in triple negative breast cancer.
by: Zoë Dinkel, et al.
Published: (2025-01-01)

PREVENTION AND MONITORING OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER
by: N. A. Kozyavin, et al.
Published: (2018-08-01)

The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score
by: Zheng‐Jun Yang, et al.
Published: (2023-02-01)

ASSOCIATION BETWEEN SPECIFIC FEATURES OF GATA3 TRANSCRIPTION FACTOR EXPRESSION AND LYMPH NODE METASTASIS IN LUMINAL BREAST CANCER
by: S. V. Vtorushin, et al.
Published: (2017-11-01)

SYNTHESIS AND CRYSTAL STRUCTURE OF [PPh ] [WOS (CUNCS) ]
Published: (1996-12-01)

Spectrophotometric Study of Adduct Formation Between [Co(Salen)PPh3]ClO4.H2O and [Co(7,7'-Dimethylsalen)PPh3]ClO4.H2O with Amines Donors in Acetonitrile
by: Mahmood Niad, et al.
Published: (2010-01-01)

Curcumin Enhances Antimigration of Pentagamavunon-1 by Suppressing MMP-2 and MMP-9 Expression in Triple-Negative (4T1) and Luminal A (T47D) Breast Cancer Cells
by: Desty Restia Rahmawati, et al.
Published: (2025-02-01)

Diagnostic Accuracy of Combined 3.0T Magnetic Resonance Imaging and Molybdenum Target X-Ray in Triple-Negative Breast Cancer: Correlation with Prognosis in Patients Undergoing Sentinel Lymph Node Biopsy
by: Li Xia, et al.
Published: (2024-04-01)